Search Results - Lars Zender

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    NUT Carcinoma—An Underdiagnosed Malignancy by Ulrich M. Lauer, Ulrich M. Lauer, Ulrich M. Lauer, Martina Hinterleitner, Martina Hinterleitner, Martina Hinterleitner, Marius Horger, Marius Horger, Paul V. Ohnesorge, Paul V. Ohnesorge, Paul V. Ohnesorge, Lars Zender, Lars Zender, Lars Zender

    Published in Frontiers in Oncology (2022-07-01)
    Get full text
    Article


  2. 2

    Long-term prognostic factors for PRRT in neuroendocrine tumors by Nils Florian Trautwein, Nils Florian Trautwein, Nils Florian Trautwein, Johannes Schwenck, Johannes Schwenck, Johannes Schwenck, Johann Jacoby, Gerald Reischl, Gerald Reischl, Francesco Fiz, Francesco Fiz, Lars Zender, Lars Zender, Lars Zender, Lars Zender, Helmut Dittmann, Helmut Dittmann, Martina Hinterleitner, Martina Hinterleitner, Martina Hinterleitner, Christian la Fougère, Christian la Fougère, Christian la Fougère, Christian la Fougère

    Published in Frontiers in Medicine (2023-06-01)
    Get full text
    Article


  3. 3

    Case report: Pulmonary Ewing sarcoma disguised as non-small cell lung cancer by Mary E. Carter, Alessia Benegiamo-Chilla, Linus D. Kloker, Nikolas Paulsen, Vlatko Potkrajcic, Frank Paulsen, Attila Nemeth, Volker Steger, Martin Schulze, Saskia Biskup, Saskia Biskup, Katrin Benzler, Stephan Singer, Ulrich M. Lauer, Ulrich M. Lauer, Ulrich M. Lauer, Lars Zender, Lars Zender, Lars Zender, Christoph K. W. Deinzer

    Published in Frontiers in Oncology (2024-11-01)
    Get full text
    Article


  4. 4

    Variability of Metabolic Rate and Distribution Volume Quantification in Whole-Body Parametric PATLAK [<sup>18</sup>F]-FDG PET/CT—A Prospective Trial in Patients with Lung Cancer by Stephan Ursprung, Lars Zender, Patrick Ghibes, Florian Hagen, Konstantin Nikolaou, Christian la Fougère, Matthias Weissinger

    Published in Diagnostics (2025-07-01)
    Get full text
    Article


  5. 5

    Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3 by Martina Hinterleitner, Martina Hinterleitner, Martina Hinterleitner, Ruben Pfeiffer, Nils F. Trautwein, Nils F. Trautwein, Bence Sipos, Bence Sipos, Bence Sipos, Stephan Singer, Stephan Singer, Silvio Nadalin, Silvio Nadalin, Alfred Königsrainer, Alfred Königsrainer, Ulrich M. Lauer, Ulrich M. Lauer, Ulrich M. Lauer, Ulrich M. Lauer, Christian la Fougère, Christian la Fougère, Christian la Fougère, Christian la Fougère, Lars Zender, Lars Zender, Lars Zender, Lars Zender, Clemens Hinterleitner, Clemens Hinterleitner, Clemens Hinterleitner, Clemens Hinterleitner

    Published in Frontiers in Endocrinology (2024-01-01)
    Get full text
    Article


  6. 6

    Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression by Susanne M. Rittig, Susanne M. Rittig, Martina S. Lutz, Martina S. Lutz, Kim L. Clar, Kim L. Clar, Yanjun Zhou, Yanjun Zhou, Korbinian N. Kropp, André Koch, Andreas D. Hartkopf, Andreas D. Hartkopf, Martina Hinterleitner, Martina Hinterleitner, Lars Zender, Lars Zender, Lars Zender, Helmut R. Salih, Helmut R. Salih, Stefanie Maurer, Stefanie Maurer, Stefanie Maurer, Clemens Hinterleitner, Clemens Hinterleitner, Clemens Hinterleitner

    Published in Frontiers in Oncology (2022-07-01)
    Get full text
    Article


  7. 7

    B7-H3 membranous expression correlates with histological grading in a two-center cohort of 133 pre-treatment bone and soft tissue sarcoma samples by Linus D. Kloker, Robert Rottscholl, Jonas S. Heitmann, Peter Bronsert, David Braig, Katrin Benzler, Lars Zender, Christoph K. W. Deinzer

    Published in BMC Cancer (2026-06-01)
    Get full text
    Article


  8. 8

    SarkoLife: quality of life in patients undergoing multimodal soft tissue sarcoma treatment by Sebastian Hoffmann, Tabea Hoffmann, Vlatko Potkrajcic, Christoph K. W. Deinzer, Katrin Benzler, Lars Zender, Adrien Daigeler, Johannes Tobias Thiel

    Published in World Journal of Surgical Oncology (2025-01-01)
    Get full text
    Article


  9. 9

    Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma by Linus D. Kloker, Branko Calukovic, Katrin Benzler, Alexander Golf, Sebastian Böhm, Sven Günther, Marius Horger, Simone Haas, Simone Haas, Susanne Berchtold, Julia Beil, Julia Beil, Mary E. Carter, Tina Ganzenmueller, Stephan Singer, Abbas Agaimy, Robert Stöhr, Arndt Hartmann, Thomas Duell, Sandra Mairhofer, Fabian Fohrer, Niels Reinmuth, Lars Zender, Lars Zender, Ulrich M. Lauer, Ulrich M. Lauer

    Published in Frontiers in Oncology (2022-10-01)
    Get full text
    Article


  10. 10

    Targeting CD276 with Adapter-CAR T-cells provides a novel therapeutic strategy in small cell lung cancer and prevents CD276-dependent fratricide by Beate Kristmann, Niels Werchau, Lakshmi Suresh, Elisabeth L. Pezzuto, Sophia Scheuermann, Simon Krost, Karin Schilbach, Moustafa Moustafa-Oglou, Anna-Sophia Mast, Miriam Droste, André Felsberger, Lukas Kiefer, Pierre Abramowski, Lars Zender, Joerg Mittelstaet, Christian M. Seitz

    Published in Journal of Hematology & Oncology (2025-07-01)
    Get full text
    Article


  11. 11

    Actionable heterogeneity of hepatocellular carcinoma therapy-induced senescence by Pujan Engels, Andras Szolek, Sebastian Hörner, Georgios Vavouras Syrigos, Kim Hebbel, Michelle Schmidtke, Min Zhou, Maria Mateo-Tortola, Caroline Schönfeld, Sylwia Anna Stefanczyk, Katharina Wolter, Sepideh Babaei, Michael Schindler, Manfred Claassen, Daniel Dauch, Lars Zender, Ana Tapía-Abellán, Alexander N. R. Weber

    Published in Cancer Immunology, Immunotherapy (2025-05-01)
    Get full text
    Article


  12. 12

    Influence of Biopsy Technique on Molecular Genetic Tumor Characterization in Non-Small Cell Lung Cancer—The Prospective, Randomized, Single-Blinded, Multicenter PROFILER Study Prot... by Maik Haentschel, Michael Boeckeler, Irina Bonzheim, Florian Schimmele, Werner Spengler, Franz Stanzel, Christoph Petermann, Kaid Darwiche, Lars Hagmeyer, Reinhard Buettner, Markus Tiemann, Hans-Ulrich Schildhaus, Rainer Muche, Hans Boesmueller, Felix Everinghoff, Robert Mueller, Bijoy Atique, Richard A. Lewis, Lars Zender, Falko Fend, Juergen Hetzel

    Published in Diagnostics (2020-07-01)
    Get full text
    Article


  13. 13

    An IgG‐based bispecific antibody for improved dual targeting in PSMA‐positive cancer by Latifa Zekri, Fabian Vogt, Lukas Osburg, Stefanie Müller, Joseph Kauer, Timo Manz, Martin Pflügler, Andreas Maurer, Jonas S Heitmann, Ilona Hagelstein, Melanie Märklin, Sebastian Hörner, Tilmann Todenhöfer, Carsten Calaminus, Arnulf Stenzl, Bernd Pichler, Christian la Fougère, Marc A Schneider, Hans‐Georg Rammensee, Lars Zender, Bence Sipos, Helmut R Salih, Gundram Jung

    Published in EMBO Molecular Medicine (2020-12-01)
    Get full text
    Article


  14. 14

    A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine by Pauline Latzer, Henning Zelba, Florian Battke, Annekathrin Reinhardt, Borong Shao, Oliver Bartsch, Armin Rabsteyn, Johannes Harter, Martin Schulze, Thomas Okech, Alexander Golf, Christina Kyzirakos-Feger, Simone Kayser, Natalia Pieper, Magdalena Feldhahn, Julian Wünsche, Christian Seitz, Dirk Hadaschik, Claus Garbe, Till-Karsten Hauser, Christian la Fougère, Dirk Biskup, Dawn Brooke, David Parker, Uwe M. Martens, Gerald Illerhaus, Deborah T. Blumenthal, Ryan Merrell, Luisa Sánchez Lorenzo, Máté Hidvégi, Paula de Robles, Sied Kebir, William W. Li, Vincent W. Li, Matthew Williams, Alexandra M. Miller, Santosh Kesari, Michael Castro, Annick Desjardins, David M. Ashley, Henry S. Friedman, Patrick Y. Wen, Elisabeth C. Neil, Fabio M. Iwamoto, Bence Sipos, Karsten Geletneky, Lars Zender, Martin Glas, David A. Reardon, Saskia Biskup

    Published in Nature Communications (2024-08-01)
    Get full text
    Article


Search Tools: